Loading...

IOBT IO BIOTECH INC Management Changes 8-K Filing

BTC

BT

IO BIOTECH INC

(IOBT)

2025 8-K

Management Change

Investor Conference Update

Financial Results

Restructuring Plan

Financial Results Report

Equity Offerings

Financial Statements

Equity Offerings

Financial Update

Nasdaq Compliance Notice

Financing Agreement

Bylaw Amendments

Financial Results

Trial Continuation

Financial Results

Annual Meeting of Stockholders

Financial Results Announcement

Earnings Reports

Participation in Conference

Financial Results and Appoi...

Financial Results and Direc...

Private Placement

Clinical Trial Expansion

Annual Meeting of Stockholders

Earnings Reports

Resignation of Director

Earnings Reports

Results of Operations and F...

Regulation FD Disclosure

Financial Condition

External Links:

On June 19, 2025, IO Biotech, Inc. updated the service agreement for CEO Mai-Britt Zocca, detailing severance pay and benefits, including 12 months' salary and equity vesting upon termination under specific conditions, which increases to 18 months if a change in control occurs.

AI Assistant

IO BIOTECH INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.